FindTrial
Sign In

To study the effectiveness of fenugreek in the management of potentially malignant disorders

Study of effectiveness of fenugreek as an Adjuvant in the management of four commonly occurring potentially malignant disorders in a Public teaching Dental institution in Chennai - A Randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/03/031660
Enrollment
40
Registered
2021-03-02
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K132- Leukoplakia and other disturbancesof oral epithelium, including tongue Health Condition 2: K132- Leukoplakia and other disturbancesof oral epithelium, including tongue Health Condition 3: L439- Lichen planus, unspecified Health Condition 4: K135- Oral submucous fibrosis

Interventions

Intervention1: Standardized treatment protocol with fenugreek: 2 gm bid, oral for three months Control Intervention1: Standardized treatment protocol: standardized treatment protocol

Sponsors

Nandhini Balasundaram
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adults aged 18 year and above pre-diagnosed with oral potentially malignant disorders as per the operational definition.

Exclusion criteria

Exclusion criteria: Subjects with reported hypersensitivity to fenugreek (nasal congestion, coughing, wheezing, facial swelling and allergic reaction). Subjects with malignant tumours of oral cavity. Subjects who are under medication for any other systemic illness.

Design outcomes

Primary

MeasureTime frame
Clinical evaluation in terms of reduction of progression of lesion Timepoint: Three months—

Secondary

MeasureTime frame
Compliance of patientsTimepoint: Three months—

Countries

India

Contacts

Public ContactNANDHINI BALASUNDARAM

The Tamil Nadu Dr. M.G.R. Medical University

mban1965@yahoo.com9840127997

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026